speb/financial-data huggingface dataset:
ICG income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 74432000.00
ICG income_statement (quarterly, 2025-09-30) — Net Interest Income: 2368000.00
ICG income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2368000.00
ICG balance_sheet (quarterly, 2025-09-30) — Net PPE: 142692000.00
ICG balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 836119000.00
ICG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 40105000.00
ICG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 40105000.00
ICG income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -147592000.00
ICG income_statement (quarterly, 2025-09-30) — Normalized Income: -4930000.00
ICG income_statement (quarterly, 2025-09-30) — Operating Income: -41776000.00
ICG income_statement (quarterly, 2025-09-30) — Operating Revenue: 9145000.00
ICG balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 121423854.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 80685000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 52964000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -1000.00
ICG income_statement (quarterly, 2025-09-30) — Other Gand A: 7615000.00
ICG income_statement (quarterly, 2025-09-30) — Other Income Expense: 108449000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 266713000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 8347000.00
ICG income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2633000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Properties: 142692000.00
ICG balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 193201000.00
ICG balance_sheet (quarterly, 2025-09-30) — Payables: 5428000.00
ICG balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 19959000.00
ICG income_statement (quarterly, 2025-09-30) — Pretax Income: 69041000.00
ICG income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 18220000.00
ICG income_statement (quarterly, 2025-09-30) — Research And Development: 22651000.00
ICG balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 840815000.00
ICG income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2435000.00
ICG income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10050000.00
ICG balance_sheet (quarterly, 2025-09-30) — Share Issued: 121484348.00
ICG balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1102832000.00
ICG balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 836119000.00
ICG income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 26454000.00
ICG income_statement (quarterly, 2025-09-30) — Tax Provision: -5391000.00
ICG income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
ICG balance_sheet (quarterly, 2025-09-30) — Total Assets: 1142967000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1102832000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Debt: 0.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1102832000.00
ICG income_statement (quarterly, 2025-09-30) — Total Expenses: 50921000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 40135000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 479504000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ICG income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -41776000.00
ICG balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
ICG income_statement (quarterly, 2025-09-30) — Total Unusual Items: 105816000.00
ICG income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 105816000.00
ICG balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 60494.00
ICG balance_sheet (quarterly, 2025-09-30) — Working Capital: 623328000.00
ICG income_statement (annual, 2025-12-31) — +Operating Expense: 112018000.00
ICG income_statement (quarterly, 2025-12-31) — +Operating Expense: 14441000.00
ICG income_statement (annual, 2025-12-31) — +Total Revenue: 220864000.00
ICG income_statement (quarterly, 2025-12-31) — +Total Revenue: 36131000.00
ICG balance_sheet (annual, 2025-12-31) — Accounts Payable: 3025000.00
ICG balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3025000.00
ICG balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 584000.00
ICG balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 584000.00
ICG balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -16938000.00
ICG balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -16938000.00
ICG balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 211276000.00
ICG balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 211276000.00
ICG cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 636000.00
ICG cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 636000.00
ICG cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 317000.00
ICG income_statement (quarterly, 2025-12-31) — Basic Average Shares: 60711927.00
ICG income_statement (quarterly, 2025-12-31) — Basic EPS: -2.16
ICG cash_flow (annual, 2025-12-31) — Beginning Cash Position: 322252000.00
ICG balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 138680000.00
ICG balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 138680000.00
ICG cash_flow (annual, 2025-12-31) — Capital Expenditure: -4716000.00
ICG balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1100000.00
ICG balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1100000.00
ICG balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
ICG balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
ICG balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 221661000.00
ICG balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 221661000.00
ICG balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 468092000.00
ICG balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 468092000.00
ICG balance_sheet (annual, 2025-12-31) — Cash Equivalents: 428000.00
ICG balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 428000.00
ICG balance_sheet (annual, 2025-12-31) — Cash Financial: 221233000.00
ICG balance_sheet (quarterly, 2025-12-31) — Cash Financial: 221233000.00
ICG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7390000.00
ICG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -12307000.00
ICG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -92928000.00
ICG cash_flow (annual, 2025-12-31) — Change In Account Payable: -11822000.00
ICG cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -8446000.00
ICG cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -1984000.00
ICG cash_flow (annual, 2025-12-31) — Change In Inventory: -50126000.00
ICG cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
ICG cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -12101000.00
ICG cash_flow (annual, 2025-12-31) — Change In Payable: -13806000.00
ICG cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -22252000.00
ICG cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 18801000.00
ICG cash_flow (annual, 2025-12-31) — Change In Tax Payable: -1984000.00
ICG cash_flow (annual, 2025-12-31) — Change In Working Capital: -65678000.00
ICG cash_flow (annual, 2025-12-31) — Changes In Cash: -97845000.00
ICG balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
ICG balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
ICG balance_sheet (annual, 2025-12-31) — Common Stock Equity: 972045000.00
ICG balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 972045000.00
ICG cash_flow (annual, 2025-12-31) — Common Stock Issuance: 10065000.00
ICG balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
ICG balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
ICG income_statement (annual, 2025-12-31) — Cost Of Revenue: 204902000.00
ICG income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 96730000.00
ICG balance_sheet (annual, 2025-12-31) — Current Assets: 582006000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Assets: 582006000.00
ICG balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 542000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 542000.00
ICG balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 542000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 542000.00
ICG balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 16462000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 16462000.00
ICG balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 16462000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 16462000.00
ICG balance_sheet (annual, 2025-12-31) — Current Liabilities: 42788000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 42788000.00
ICG balance_sheet (annual, 2025-12-31) — Current Provisions: 380000.00
ICG balance_sheet (quarterly, 2025-12-31) — Current Provisions: 380000.00
ICG cash_flow (annual, 2025-12-31) — Deferred Income Tax: -36854000.00
ICG cash_flow (annual, 2025-12-31) — Deferred Tax: -36854000.00
ICG cash_flow (annual, 2025-12-31) — Depreciation: 6179000.00
ICG cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 6815000.00
ICG cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 6815000.00
ICG income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 60711927.00
ICG income_statement (quarterly, 2025-12-31) — Diluted EPS: -2.16
ICG income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -126219000.00
ICG income_statement (annual, 2025-12-31) — EBIT: -83815000.00
ICG income_statement (quarterly, 2025-12-31) — EBIT: -62799000.00
ICG income_statement (annual, 2025-12-31) — EBITDA: -77000000.00
ICG income_statement (quarterly, 2025-12-31) — EBITDA: -62799000.00
ICG cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -2746000.00
ICG cash_flow (annual, 2025-12-31) — End Cash Position: 221661000.00
ICG cash_flow (annual, 2025-12-31) — Financing Cash Flow: 7390000.00
ICG balance_sheet (annual, 2025-12-31) — Finished Goods: 62254000.00
ICG balance_sheet (quarterly, 2025-12-31) — Finished Goods: 62254000.00
ICG cash_flow (annual, 2025-12-31) — Free Cash Flow: -97644000.00
ICG cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4779000.00
ICG cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 38000.00
ICG income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 2062000.00
ICG income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -75246000.00
ICG balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 50722000.00
ICG balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 50722000.00
ICG income_statement (annual, 2025-12-31) — General And Administrative Expense: 34445000.00
ICG income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7813000.00
ICG balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 199582000.00
ICG balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 199582000.00
ICG balance_sheet (annual, 2025-12-31) — Gross PPE: 159619000.00
ICG balance_sheet (quarterly, 2025-12-31) — Gross PPE: 159619000.00
ICG income_statement (annual, 2025-12-31) — Gross Profit: 15962000.00
ICG income_statement (quarterly, 2025-12-31) — Gross Profit: -60599000.00
ICG income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 74000.00
ICG cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1707000.00
ICG balance_sheet (annual, 2025-12-31) — Income Tax Payable: 39000.00
ICG balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 39000.00
ICG income_statement (annual, 2025-12-31) — Interest Expense: 40000.00
ICG income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 40000.00
ICG income_statement (annual, 2025-12-31) — Interest Income: 11014000.00
ICG income_statement (quarterly, 2025-12-31) — Interest Income: 2412000.00
ICG income_statement (annual, 2025-12-31) — Interest Income Non Operating: 11014000.00
ICG income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2412000.00
ICG balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -156977000.00
ICG balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -156977000.00
ICG balance_sheet (annual, 2025-12-31) — Inventory: 52151000.00
ICG balance_sheet (quarterly, 2025-12-31) — Inventory: 52151000.00
ICG balance_sheet (annual, 2025-12-31) — Invested Capital: 972045000.00
ICG balance_sheet (quarterly, 2025-12-31) — Invested Capital: 972045000.00
ICG cash_flow (annual, 2025-12-31) — Investing Cash Flow: -12307000.00
ICG balance_sheet (annual, 2025-12-31) — Investments And Advances: 21486000.00
ICG balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 21486000.00
ICG cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 10065000.00
ICG balance_sheet (annual, 2025-12-31) — Leases: 0.00
ICG balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
ICG balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 558000.00
ICG balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 558000.00
ICG balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 558000.00
ICG balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 558000.00
ICG balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 19839000.00
ICG balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 19839000.00
ICG cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 10065000.00
ICG cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 2869000.00
ICG income_statement (annual, 2025-12-31) — Net Income: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income: -126219000.00
ICG income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -126219000.00
ICG income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -126219000.00
ICG income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -126219000.00
ICG income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -126219000.00
ICG cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -47532000.00
ICG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -47532000.00
ICG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -126219000.00
ICG cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
ICG income_statement (annual, 2025-12-31) — Net Interest Income: 10974000.00
ICG income_statement (quarterly, 2025-12-31) — Net Interest Income: 2372000.00
ICG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -44277000.00
ICG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 10974000.00
ICG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 2372000.00
ICG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2675000.00
ICG cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 20140000.00
ICG balance_sheet (annual, 2025-12-31) — Net PPE: 142681000.00
ICG balance_sheet (quarterly, 2025-12-31) — Net PPE: 142681000.00
ICG cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 11830000.00
ICG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 772463000.00
ICG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 772463000.00
ICG balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 61289000.00
ICG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 61289000.00
ICG balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 61289000.00
ICG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 61289000.00
ICG income_statement (annual, 2025-12-31) — Normalized EBITDA: -78988000.00
ICG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 12521000.00
ICG income_statement (annual, 2025-12-31) — Normalized Income: -49023000.00
ICG income_statement (quarterly, 2025-12-31) — Normalized Income: -63571124.68
ICG cash_flow (annual, 2025-12-31) — Operating Cash Flow: -92928000.00
ICG cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1872000.00
ICG income_statement (annual, 2025-12-31) — Operating Income: -96056000.00
ICG income_statement (quarterly, 2025-12-31) — Operating Income: -75040000.00
ICG income_statement (annual, 2025-12-31) — Operating Revenue: 220864000.00
ICG income_statement (quarterly, 2025-12-31) — Operating Revenue: 36131000.00
ICG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 121423854.00
ICG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 121423854.00
ICG balance_sheet (annual, 2025-12-31) — Other Current Assets: 7115000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 7115000.00
ICG balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2866000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2866000.00
ICG balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 50722000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 50722000.00
ICG balance_sheet (annual, 2025-12-31) — Other Equity Interest: -1000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -1000.00
ICG income_statement (annual, 2025-12-31) — Other Gand A: 34445000.00
ICG income_statement (quarterly, 2025-12-31) — Other Gand A: 7813000.00
ICG income_statement (annual, 2025-12-31) — Other Income Expense: 1227000.00
ICG income_statement (quarterly, 2025-12-31) — Other Income Expense: -79082000.00
ICG balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 199582000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 199582000.00
ICG cash_flow (annual, 2025-12-31) — Other Non Cash Items: -49562000.00
ICG balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 8347000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 8347000.00
ICG income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -761000.00
ICG income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -3762000.00
ICG income_statement (annual, 2025-12-31) — Other Operating Expenses: -8547000.00
ICG balance_sheet (annual, 2025-12-31) — Other Payable: 16014000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Payable: 16014000.00
ICG balance_sheet (annual, 2025-12-31) — Other Properties: 1100000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Properties: 1100000.00
ICG balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 246431000.00
ICG balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 246431000.00
ICG balance_sheet (annual, 2025-12-31) — Payables: 22538000.00
ICG balance_sheet (quarterly, 2025-12-31) — Payables: 22538000.00
ICG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 22538000.00
ICG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 22538000.00
ICG balance_sheet (annual, 2025-12-31) — Prepaid Assets: 5111000.00
ICG balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 5111000.00
ICG income_statement (annual, 2025-12-31) — Pretax Income: -83855000.00
ICG income_statement (quarterly, 2025-12-31) — Pretax Income: -151750000.00
ICG balance_sheet (annual, 2025-12-31) — Properties: 0.00
ICG balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ICG cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 92809000.00
ICG cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
ICG cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1119846000.00
ICG cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4716000.00
ICG balance_sheet (annual, 2025-12-31) — Raw Materials: 26684000.00
ICG balance_sheet (quarterly, 2025-12-31) — Raw Materials: 26684000.00
ICG balance_sheet (annual, 2025-12-31) — Receivables: 49537000.00
ICG balance_sheet (quarterly, 2025-12-31) — Receivables: 49537000.00
ICG income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 204902000.00
ICG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 96730000.00
ICG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 6815000.00
ICG income_statement (annual, 2025-12-31) — Research And Development: 77296000.00
ICG income_statement (quarterly, 2025-12-31) — Research And Development: 13053000.00
ICG balance_sheet (annual, 2025-12-31) — Retained Earnings: 710047000.00
ICG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 710047000.00
ICG cash_flow (annual, 2025-12-31) — Sale Of Investment: 1075569000.00
ICG cash_flow (annual, 2025-12-31) — Sale Of PPE: 16546000.00
ICG income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 8824000.00
ICG income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2122000.00
ICG income_statement (annual, 2025-12-31) — Selling General And Administration: 43269000.00
ICG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9935000.00
ICG balance_sheet (annual, 2025-12-31) — Share Issued: 121484348.00
ICG balance_sheet (quarterly, 2025-12-31) — Share Issued: 121484348.00
ICG income_statement (annual, 2025-12-31) — Special Income Charges: -74000.00
ICG cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8650000.00
ICG balance_sheet (annual, 2025-12-31) — Stockholders Equity: 972045000.00
ICG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 972045000.00
ICG balance_sheet (annual, 2025-12-31) — Tangible Book Value: 772463000.00
ICG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 772463000.00
ICG income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 497000.00
ICG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -12672124.68
ICG income_statement (annual, 2025-12-31) — Tax Provision: -36323000.00
ICG income_statement (quarterly, 2025-12-31) — Tax Provision: -25531000.00
ICG income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
ICG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
ICG balance_sheet (annual, 2025-12-31) — Taxes Receivable: 48953000.00
ICG balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 48953000.00
ICG balance_sheet (annual, 2025-12-31) — Total Assets: 1015391000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Assets: 1015391000.00
ICG balance_sheet (annual, 2025-12-31) — Total Capitalization: 972045000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 972045000.00
ICG balance_sheet (annual, 2025-12-31) — Total Debt: 1100000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Debt: 1100000.00
ICG balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 972045000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 972045000.00
ICG income_statement (annual, 2025-12-31) — Total Expenses: 316920000.00
ICG income_statement (quarterly, 2025-12-31) — Total Expenses: 111171000.00
ICG balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 43346000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 43346000.00
ICG balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 433385000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 433385000.00
ICG balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 558000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 558000.00
ICG income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -104677000.00
ICG income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -83661000.00
ICG balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3499000.00
ICG balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3499000.00
ICG income_statement (annual, 2025-12-31) — Total Unusual Items: 1988000.00
ICG income_statement (quarterly, 2025-12-31) — Total Unusual Items: -75320000.00
ICG income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1988000.00
ICG income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -75320000.00
ICG balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 60494.00
ICG balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 60494.00
ICG cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -21000.00
ICG balance_sheet (annual, 2025-12-31) — Work In Process: 120190000.00
ICG balance_sheet (quarterly, 2025-12-31) — Work In Process: 120190000.00
ICG balance_sheet (annual, 2025-12-31) — Working Capital: 539218000.00
ICG balance_sheet (quarterly, 2025-12-31) — Working Capital: 539218000.00
ICG.L income_statement (annual, 2022-03-31) — +Operating Expense: 199100000.00
ICG.L income_statement (annual, 2022-03-31) — +Total Revenue: 764500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 434400000.00
ICG.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -23100000.00
ICG.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 185300000.00
ICG.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 581200000.00
ICG.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -7800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Capital Stock: 77300000.00
ICG.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 761500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 991800000.00
ICG.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -165700000.00
ICG.L balance_sheet (annual, 2022-03-31) — Cash Financial: 761500000.00
ICG.L cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 0.00
ICG.L cash_flow (annual, 2022-03-31) — Change In Payable: -27400000.00
ICG.L cash_flow (annual, 2022-03-31) — Change In Receivables: -32500000.00
ICG.L cash_flow (annual, 2022-03-31) — Change In Working Capital: -59900000.00
ICG.L cash_flow (annual, 2022-03-31) — Changes In Cash: 400200000.00
ICG.L balance_sheet (annual, 2022-03-31) — Common Stock: 77300000.00
ICG.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -165700000.00
ICG.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1971800000.00
ICG.L cash_flow (annual, 2022-03-31) — Common Stock Payments: -20900000.00
ICG.L cash_flow (annual, 2022-03-31) — Depreciation: 19500000.00
ICG.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 19500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 156300000.00
ICG.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 526800000.00
ICG.L cash_flow (annual, 2022-03-31) — Dividend Received Cfo: 38000000.00
ICG.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 10400000.00
ICG.L cash_flow (annual, 2022-03-31) — End Cash Position: 991800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6973100000.00
ICG.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: 111300000.00
ICG.L cash_flow (annual, 2022-03-31) — Free Cash Flow: 235600000.00
ICG.L cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -356000000.00
ICG.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 101000000.00
ICG.L balance_sheet (annual, 2022-03-31) — Goodwill: 4300000.00
ICG.L balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 17100000.00
ICG.L balance_sheet (annual, 2022-03-31) — Gross PPE: 83500000.00
ICG.L income_statement (annual, 2022-03-31) — Interest Expense: 47400000.00
ICG.L income_statement (annual, 2022-03-31) — Interest Income: 0.00
ICG.L cash_flow (annual, 2022-03-31) — Interest Paid Cfo: -183300000.00
ICG.L cash_flow (annual, 2022-03-31) — Interest Received Cfo: 221800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Invested Capital: 7989900000.00
ICG.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: 45500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Investment Properties: 1500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 7111700000.00
ICG.L balance_sheet (annual, 2022-03-31) — Investments And Advances: 7113900000.00
ICG.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 413500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 6018100000.00
ICG.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 413500000.00
ICG.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -115600000.00
ICG.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 2200000.00
ICG.L balance_sheet (annual, 2022-03-31) — Minority Interest: 30000000.00
ICG.L income_statement (annual, 2022-03-31) — Minority Interests: 1700000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 30900000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -20900000.00
ICG.L balance_sheet (annual, 2022-03-31) — Net Debt: 5256600000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 100000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income: 526800000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 526800000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 534300000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: -9200000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 526800000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 536000000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 565400000.00
ICG.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 525100000.00
ICG.L income_statement (annual, 2022-03-31) — Net Interest Income: -47400000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 22400000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 297900000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 297900000.00
ICG.L cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 0.00
ICG.L balance_sheet (annual, 2022-03-31) — Net PPE: 60400000.00
ICG.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -7800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1954700000.00
ICG.L income_statement (annual, 2022-03-31) — Normalized Income: 536000000.00
ICG.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: 243400000.00
ICG.L income_statement (annual, 2022-03-31) — Operating Revenue: 764500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 290552471.00
ICG.L balance_sheet (annual, 2022-03-31) — Other Equity Interest: 67500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 12800000.00
ICG.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: -351300000.00
ICG.L income_statement (annual, 2022-03-31) — Other Operating Expenses: 5700000.00
ICG.L balance_sheet (annual, 2022-03-31) — Other Payable: 76400000.00
ICG.L balance_sheet (annual, 2022-03-31) — Payables: 525300000.00
ICG.L balance_sheet (annual, 2022-03-31) — Prepaid Assets: 2800000.00
ICG.L income_statement (annual, 2022-03-31) — Pretax Income: 565400000.00
ICG.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -7800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Receivables: 371400000.00
ICG.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 19500000.00
ICG.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: -115600000.00
ICG.L cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -20900000.00
ICG.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 1714000000.00
ICG.L income_statement (annual, 2022-03-31) — Selling General And Administration: 101000000.00
ICG.L balance_sheet (annual, 2022-03-31) — Share Issued: 294285804.00
ICG.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1971800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1954700000.00
ICG.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
ICG.L income_statement (annual, 2022-03-31) — Tax Provision: 31100000.00
ICG.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.06
ICG.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 31900000.00
ICG.L cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -43900000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Assets: 8872500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 7989900000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Debt: 6018100000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2001800000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 6870700000.00
ICG.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 14500000.00
ICG.L balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 3733333.00
ICG.L balance_sheet (annual, 2022-03-31) — Treasury Stock: 93000000.00
ICG.L income_statement (annual, 2023-03-31) — +Operating Expense: 348000000.00
ICG.L income_statement (annual, 2023-03-31) — +Total Revenue: 599000000.00
ICG.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 468300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -24000000.00
ICG.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 185900000.00
ICG.L cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 6700000.00
ICG.L balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 4700000.00
ICG.L income_statement (annual, 2023-03-31) — Basic Average Shares: 285613961.00
ICG.L income_statement (annual, 2023-03-31) — Basic EPS: 0.98
ICG.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 991800000.00
ICG.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -11200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Capital Stock: 77300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 550000000.00
ICG.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 957500000.00
ICG.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -236400000.00
ICG.L balance_sheet (annual, 2023-03-31) — Cash Financial: 550000000.00
ICG.L cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 0.00
ICG.L cash_flow (annual, 2023-03-31) — Change In Payable: -196900000.00
ICG.L cash_flow (annual, 2023-03-31) — Change In Receivables: -12000000.00
ICG.L cash_flow (annual, 2023-03-31) — Change In Working Capital: -208900000.00
ICG.L cash_flow (annual, 2023-03-31) — Changes In Cash: -54300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Common Stock: 77300000.00
ICG.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -236400000.00
ICG.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2019800000.00
ICG.L cash_flow (annual, 2023-03-31) — Common Stock Payments: -38900000.00
ICG.L cash_flow (annual, 2023-03-31) — Depreciation: 11500000.00
ICG.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 18200000.00
ICG.L income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 18200000.00
ICG.L income_statement (annual, 2023-03-31) — Depreciation Income Statement: 18200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 15700000.00
ICG.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 289312915.00
ICG.L income_statement (annual, 2023-03-31) — Diluted EPS: 0.97
ICG.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 280600000.00
ICG.L cash_flow (annual, 2023-03-31) — Dividend Received Cfo: 40200000.00
ICG.L cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 20000000.00
ICG.L cash_flow (annual, 2023-03-31) — End Cash Position: 957500000.00
ICG.L balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7036600000.00
ICG.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: -476700000.00
ICG.L cash_flow (annual, 2023-03-31) — Free Cash Flow: 280400000.00
ICG.L cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -2000000.00
ICG.L income_statement (annual, 2023-03-31) — General And Administrative Expense: 65600000.00
ICG.L balance_sheet (annual, 2023-03-31) — Goodwill: 4300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 14900000.00
ICG.L balance_sheet (annual, 2023-03-31) — Gross PPE: 112200000.00
ICG.L income_statement (annual, 2023-03-31) — Interest Expense: 59900000.00
ICG.L income_statement (annual, 2023-03-31) — Interest Income: 0.00
ICG.L cash_flow (annual, 2023-03-31) — Interest Paid Cfo: -263400000.00
ICG.L cash_flow (annual, 2023-03-31) — Interest Received Cfo: 322600000.00
ICG.L balance_sheet (annual, 2023-03-31) — Invested Capital: 8129200000.00
ICG.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: 130800000.00
ICG.L balance_sheet (annual, 2023-03-31) — Investment Properties: 800000.00
ICG.L balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 7063300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Investments And Advances: 7069100000.00
ICG.L cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
ICG.L balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 6115200000.00
ICG.L cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
ICG.L cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -201400000.00
ICG.L balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 5800000.00
ICG.L balance_sheet (annual, 2023-03-31) — Minority Interest: 25400000.00
ICG.L income_statement (annual, 2023-03-31) — Minority Interests: 2200000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 200800000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -38900000.00
ICG.L balance_sheet (annual, 2023-03-31) — Net Debt: 5559400000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -17800000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income: 280600000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 280600000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 221600000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 56800000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 280600000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 223800000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 251000000.00
ICG.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 278400000.00
ICG.L income_statement (annual, 2023-03-31) — Net Interest Income: -59900000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -58800000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -201400000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -201400000.00
ICG.L cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 0.00
ICG.L balance_sheet (annual, 2023-03-31) — Net PPE: 88200000.00
ICG.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -11200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2004900000.00
ICG.L income_statement (annual, 2023-03-31) — Normalized Income: 223800000.00
ICG.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: 291600000.00
ICG.L income_statement (annual, 2023-03-31) — Operating Revenue: 599000000.00
ICG.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 290598849.00
ICG.L balance_sheet (annual, 2023-03-31) — Other Equity Interest: 73300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 10600000.00
ICG.L cash_flow (annual, 2023-03-31) — Other Non Cash Items: -403800000.00
ICG.L income_statement (annual, 2023-03-31) — Other Operating Expenses: 4700000.00
ICG.L balance_sheet (annual, 2023-03-31) — Other Payable: 71100000.00
ICG.L balance_sheet (annual, 2023-03-31) — Payables: 557300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Prepaid Assets: 10000000.00
ICG.L income_statement (annual, 2023-03-31) — Pretax Income: 251000000.00
ICG.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -11200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Receivables: 259100000.00
ICG.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 18200000.00
ICG.L income_statement (annual, 2023-03-31) — Rent And Landing Fees: 2800000.00
ICG.L income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 2800000.00
ICG.L cash_flow (annual, 2023-03-31) — Repayment Of Debt: -201400000.00
ICG.L cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -38900000.00
ICG.L balance_sheet (annual, 2023-03-31) — Retained Earnings: 1742600000.00
ICG.L income_statement (annual, 2023-03-31) — Selling General And Administration: 65600000.00
ICG.L balance_sheet (annual, 2023-03-31) — Share Issued: 294332182.00
ICG.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2019800000.00
ICG.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2004900000.00
ICG.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
ICG.L income_statement (annual, 2023-03-31) — Tax Provision: 29400000.00
ICG.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.11
ICG.L balance_sheet (annual, 2023-03-31) — Taxes Receivable: 57000000.00
ICG.L cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -32400000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Assets: 9052500000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 8129200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Debt: 6115200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2045200000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 7007300000.00
ICG.L balance_sheet (annual, 2023-03-31) — Total Tax Payable: 17900000.00
ICG.L balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 3733333.00
ICG.L balance_sheet (annual, 2023-03-31) — Treasury Stock: 103400000.00
ICG.L income_statement (annual, 2024-03-31) — +Operating Expense: 395100000.00
ICG.L income_statement (annual, 2024-03-31) — +Total Revenue: 925900000.00
ICG.L balance_sheet (annual, 2024-03-31) — Accounts Payable: 525900000.00
ICG.L balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -32600000.00
ICG.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 186300000.00
ICG.L cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 5600000.00
ICG.L balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 73200000.00
ICG.L income_statement (annual, 2024-03-31) — Basic Average Shares: 286123236.00
ICG.L income_statement (annual, 2024-03-31) — Basic EPS: 1.66
ICG.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 957500000.00
ICG.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -9500000.00
ICG.L balance_sheet (annual, 2024-03-31) — Capital Stock: 77300000.00
ICG.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 627400000.00
ICG.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 990000000.00
ICG.L cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -223400000.00
ICG.L balance_sheet (annual, 2024-03-31) — Cash Financial: 627400000.00
ICG.L cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 0.00
ICG.L cash_flow (annual, 2024-03-31) — Change In Payable: -17700000.00
ICG.L cash_flow (annual, 2024-03-31) — Change In Receivables: -88700000.00
ICG.L cash_flow (annual, 2024-03-31) — Change In Working Capital: -106400000.00
ICG.L cash_flow (annual, 2024-03-31) — Changes In Cash: 44900000.00
ICG.L balance_sheet (annual, 2024-03-31) — Common Stock: 77300000.00
ICG.L cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -223400000.00
ICG.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2301900000.00
ICG.L cash_flow (annual, 2024-03-31) — Common Stock Payments: 0.00
ICG.L cash_flow (annual, 2024-03-31) — Depreciation: 12400000.00
ICG.L cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 18000000.00
ICG.L income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 17900000.00
ICG.L income_statement (annual, 2024-03-31) — Depreciation Income Statement: 17900000.00
ICG.L balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 9200000.00
ICG.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 292011276.00
ICG.L income_statement (annual, 2024-03-31) — Diluted EPS: 1.62
ICG.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 473400000.00
ICG.L cash_flow (annual, 2024-03-31) — Dividend Received Cfo: 47000000.00
ICG.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -12400000.00
ICG.L cash_flow (annual, 2024-03-31) — End Cash Position: 990000000.00
ICG.L balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7391500000.00
ICG.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: -282500000.00
ICG.L cash_flow (annual, 2024-03-31) — Free Cash Flow: 246400000.00
ICG.L cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -306700000.00
ICG.L income_statement (annual, 2024-03-31) — General And Administrative Expense: 76400000.00
ICG.L balance_sheet (annual, 2024-03-31) — Goodwill: 4300000.00
ICG.L balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 15000000.00
ICG.L balance_sheet (annual, 2024-03-31) — Gross PPE: 111800000.00
ICG.L income_statement (annual, 2024-03-31) — Interest Expense: 44900000.00
ICG.L income_statement (annual, 2024-03-31) — Interest Income: 0.00
ICG.L cash_flow (annual, 2024-03-31) — Interest Paid Cfo: -379500000.00
ICG.L cash_flow (annual, 2024-03-31) — Interest Received Cfo: 447200000.00
ICG.L balance_sheet (annual, 2024-03-31) — Invested Capital: 8351600000.00
ICG.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: 71500000.00
ICG.L balance_sheet (annual, 2024-03-31) — Investment Properties: 82700000.00
ICG.L balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 7474000000.00
ICG.L balance_sheet (annual, 2024-03-31) — Investments And Advances: 7474000000.00
ICG.L balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 6127900000.00
ICG.L cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -59100000.00
ICG.L balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
ICG.L balance_sheet (annual, 2024-03-31) — Minority Interest: -2200000.00